REspiratory diSEAse cohoRt Studies of CHinese Medicine for ILD (RESEARCH-ILD)

Sponsor
Henan University of Traditional Chinese Medicine
Study ID
NCT06577753
Status
Recruiting
Apply to this trial

Conditions

  • Interstitial Lung Disease

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

This study is a traditional Chinese medicine cohort for interstitial lung disease（ILD） in China, including at least 5000 patients with ILD and followed up for at least 5 years. The aim is to focus on the demographic characteristics, clinical features, disease occurrence and development characteristics, TCM syndrome evolution patterns, and clinical efficacy of TCM treatment for ILD in the real world.

Key Dates

First listed
Aug 29, 2024
Start date
Apr 15, 2024
Status verified
Dec 2023
Primary completion
Dec 30, 2029
Completion
Dec 30, 2030

Study Design

Enrollment
5,000 participants (estimated)

Arms

  • Arm: Traditional Chinese Medicine cohort
    ILD subjects who have continuously used traditional Chinese medicine for standardized treatment for 3 months or more within 1 year, or have accumulated treatment time for 6 months or more.
  • Arm: Non Traditional Chinese Medicine cohort
    Other ILD patients who do not meet the traditional Chinese medicine cohort.

Primary Outcome Measure

All-cause mortality [ Time Frame: up to week 13, 26, 39, 52, 65, 78 ,91 and 104 weeks. ]

Central Contacts

Related Studies